161 related articles for article (PubMed ID: 8602775)
21. Hereditary uveal melanoma: a report of a germline mutation in BAP1.
Höiom V; Edsgärd D; Helgadottir H; Eriksson H; All-Ericsson C; Tuominen R; Ivanova I; Lundeberg J; Emanuelsson O; Hansson J
Genes Chromosomes Cancer; 2013 Apr; 52(4):378-84. PubMed ID: 23341325
[TBL] [Abstract][Full Text] [Related]
22. Use of fluorescence in situ hybridization to distinguish metastatic uveal from cutaneous melanoma.
Fang Y; Wang X; Dusza S; Jhanwar S; Abramson D; Busam KJ
Int J Surg Pathol; 2012 Jun; 20(3):246-51. PubMed ID: 22415057
[TBL] [Abstract][Full Text] [Related]
23. Other cancers in uveal melanoma patients and their families.
Turner BJ; Siatkowski RM; Augsburger JJ; Shields JA; Lustbader E; Mastrangelo MJ
Am J Ophthalmol; 1989 Jun; 107(6):601-8. PubMed ID: 2729409
[TBL] [Abstract][Full Text] [Related]
24. [THE BRAF MUTATION AND THE POSSIBILITIES OF UVEAL MELANOMA METASTASING PROGNOSTIC MARKERS IDENTIFICATION].
Horkovičová K; Markus J; Krčová I; Babál P; Kobzová D; Smolková B
Cesk Slov Oftalmol; 2016; 72(4):149-156. PubMed ID: 27860480
[TBL] [Abstract][Full Text] [Related]
25. Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants.
Villy MC; Le Ven A; Le Mentec M; Masliah-Planchon J; Houy A; Bièche I; Vacher S; Vincent-Salomon A; Dubois d'Enghien C; Schwartz M; Piperno-Neumann S; Matet A; Malaise D; Bubien V; Lortholary A; Ait Omar A; Cavaillé M; Stoppa-Lyonnet D; Cassoux N; Stern MH; Rodrigues M; Golmard L; Colas C
J Natl Cancer Inst; 2024 Apr; 116(4):580-587. PubMed ID: 38060262
[TBL] [Abstract][Full Text] [Related]
26. Familial uveal melanoma: a report of four cases in two families and literature review.
Barker-Griffith AE; Streeten BW
Can J Ophthalmol; 2004 Jun; 39(4):403-8. PubMed ID: 15327106
[No Abstract] [Full Text] [Related]
27. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma.
Hearle N; Damato BE; Humphreys J; Wixey J; Green H; Stone J; Easton DF; Houlston RS
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):458-62. PubMed ID: 12556369
[TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
29. TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma.
Damento GM; Pulido JS; Abbott BA; Hodge DO; Dalvin LA
Mayo Clin Proc; 2019 Jul; 94(7):1287-1295. PubMed ID: 31272570
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide study on uveal melanoma patients finds association to DNA repair gene TDP1.
Thomsen H; Chattopadhyay S; Hoffmann P; Nöthen MM; Kalirai H; Coupland SE; Jonas JB; Hemminki K; Försti A
Melanoma Res; 2020 Apr; 30(2):166-172. PubMed ID: 31626034
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
[TBL] [Abstract][Full Text] [Related]
32. Expression of bcl-2 in uveal malignant melanoma.
Jay V; Yi Q; Hunter WS; Zielenska M
Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055
[TBL] [Abstract][Full Text] [Related]
33. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
[TBL] [Abstract][Full Text] [Related]
34. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
[TBL] [Abstract][Full Text] [Related]
35. Lack of association between intraocular melanoma and cutaneous dysplastic nevi.
Taylor MR; Guerry D; Bondi EE; Shields JA; Augsburger JJ; Lusk EJ; Elder DE; Clark WH; Van Horn M
Am J Ophthalmol; 1984 Oct; 98(4):478-82. PubMed ID: 6486223
[TBL] [Abstract][Full Text] [Related]
36. CDKN2A as a uveal and cutaneous melanoma susceptibility gene.
Kannengiesser C; Avril MF; Spatz A; Laud K; Lenoir GM; Bressac-de-Paillerets B
Genes Chromosomes Cancer; 2003 Nov; 38(3):265-8. PubMed ID: 14506702
[TBL] [Abstract][Full Text] [Related]
37. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
Manarang JC; Otteson DC; McDermott AM
Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
[TBL] [Abstract][Full Text] [Related]
38. Pathology and genetics of uveal melanoma.
Griewank KG; Murali R
Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
[TBL] [Abstract][Full Text] [Related]
39. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
Richtig E; Langmann G; Müllner K; Smolle J
Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
[TBL] [Abstract][Full Text] [Related]
40. Uveal vs. cutaneous melanoma. Origins and causes of the differences.
Belmar-Lopez C; Mancheno-Corvo P; Saornil MA; Baril P; Vassaux G; Quintanilla M; Martin-Duque P
Clin Transl Oncol; 2008 Mar; 10(3):137-42. PubMed ID: 18321815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
